Keyphrases
AIMS™
14%
Antibody Prophylaxis
14%
Bronchiolitis
28%
Domiciliary Oxygen
14%
Drug Acquisition Cost
14%
High-risk Infants
100%
High-risk Population
14%
Hospital Admission
14%
Hospital Costs
14%
Hospitalization Rate
14%
Local Health Authority
28%
Monoclonal Antibody
14%
Oxygen Demand
14%
Potential Impact
100%
Premature Infant
14%
Randomized Placebo-controlled Trial
14%
Relative Risk
14%
Respiratory Syncytial Virus
71%
Respiratory Syncytial Virus Infection
100%
Risk Factors
14%
Supplemental Oxygen
14%
United Kingdom
100%
Medicine and Dentistry
Bronchiolitis
28%
Health Care Cost
28%
High Risk Infant
100%
High Risk Population
14%
Hospital Cost
14%
Human Respiratory Syncytial Virus
71%
Monoclonal Antibody
14%
Oxygen Consumption
14%
Placebo
14%
Pregnancy
14%
Prematurity
14%
Respiratory Syncytial Virus Infection
100%
Immunology and Microbiology
Bronchiolitis
40%
High Risk Population
20%
Human Respiratory Syncytial Virus
100%
Monoclonal Antibody
20%
Oxygen Consumption
20%
Pregnancy
20%
Respiratory Syncytial Virus Infection
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bronchiolitis
40%
Human Respiratory Syncytial Virus
100%
Monoclonal Antibody
20%
Placebo
20%
Prematurity
20%
Respiratory Syncytial Virus Infection
100%
Nursing and Health Professions
Bronchiolitis
28%
High Risk Infant
100%
High Risk Population
14%
Hospital Cost
14%
Monoclonal Antibody
14%
Placebo
14%
Prematurity
14%
Respiratory Syncytial Virus Infection
100%